早期乳腺癌加速部分乳腺照射与全乳照射随机III期APBI-IMRT-Florence试验长期结果
该随机III期试验比较早期乳腺癌保乳术后外照射加速部分乳腺照射(APBI,30 Gy/5次,每日一次)与全乳照射(WBI,50 Gy/25次加瘤床补量)的长期疗效。APBI组急性和晚期毒性显著更低,医生和患者评估的美容效果均显著更优。
要点
- 10年同侧乳腺肿瘤复发率APBI组3.7%对WBI组2.5%,差异无统计学意义
- 两组10年总生存均为91.9%,乳腺癌特异性生存无显著差异
- APBI组急性和晚期毒性显著更低,美容效果显著更优
核心结论
- 早期乳腺癌保乳术后采用IMRT技术的外照射APBI(30 Gy/5次,每日一次)10年同侧乳腺肿瘤复发累积发生率低,与WBI无差异。
- APBI组急性和晚期治疗相关毒性及美容效果结局均显著优于WBI。
研究设计与样本
- 主要终点为5年同侧乳腺肿瘤复发差异,比较APBI 30 Gy/5次(每日一次)与WBI 50 Gy/25次加瘤床补量。
- 中位随访10.7年。
关键数值与推荐
- APBI方案:30 Gy分5次,每日一次。
- WBI方案:50 Gy分25次,加瘤床补量。
临床怎么用
- 对于>90%具有低复发风险特征的早期乳腺癌患者,保乳术后可考虑IMRT技术的外照射APBI 30 Gy/5次每日一次方案。
- APBI在急性和晚期毒性及美容效果方面显著优于WBI,可作为低复发风险早期乳腺癌保乳术后放疗的选项之一。
局限性
- 入组患者>90%具有低复发风险特征,结论推广至中高复发风险人群需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To report the long-term results of external-beam accelerated partial-breast irradiation (APBI) intensity-modulated radiation therapy (IMRT) Florence phase III trial comparing whole-breast irradiation (WBI) to APBI in early-stage breast cancer. PATIENTS AND METHODS: The primary end point was to determine the 5-year difference in ipsilateral breast tumor recurrence (IBTR) between 30 Gy in 5 once-daily fractions (APBI arm) and 50 Gy in 25 fractions with a tumor bed boost (WBI arm) after breast-conserving surgery. RESULTS: Five hundred twenty patients, more than 90% of whom had characteristics associated with low recurrence risk, were randomly assigned (WBI, n = 260; APBI, n = 260) between 2005 and 2013. Median follow-up was 10.7 years. The 10-year cumulative incidence of IBTR was 2.5% (n = 6) in the WBI and 3.7% (n = 9) in the APBI arm (hazard ratio [HR], 1.56; 95% CI, 0.55 to 4.37; P = .40). Overall survival at 10 years was 91.9% in both arms (HR, 0.95; 95% CI, 0.50 to 1.79; P = .86). Breast cancer-specific survival at 10 years was 96.7% in the WBI and 97.8% in the APBI arm (HR, 0.65; 95% CI, 0.21 to 1.99; P = .45). The APBI arm showed significantly less acute toxicity (P = .0001) and late toxicity (P = .0001) and improved cosmetic outcome as evaluated by both physician (P = .0001) and patient (P = .0001). CONCLUSION: The 10-year cumulative IBTR incidence in early breast cancer treated with external APBI using IMRT technique in 5 once-daily fractions is low and not different from that after WBI. Acute and late treatment-related toxicity and cosmesis outcomes were significantly in favor of APBI.
引用
- Meattini I, Marrazzo L, Saieva C, et al. Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial. J Clin Oncol. 2020. PMID: 32840419. doi:10.1200/JCO.20.00650
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。